GILT--A randomised phase III study of oral vinorelbine and cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral vinorelbine and cisplatin or best supportive care alone in stage III non-small cell lung cancer.

待确认 10 由 123 发布于 2026/8/4 15:03:10

DOI:10.1007/s00066-016-0941-8
作者：Michael Flentje,?Rudolf M Huber,?Walburga Engel-Riedel,?Stefan Andreas,?Jens Kollmeier,?Susanne Staar,?Nicolas Dickgreber,?Nathalie Vaissiere,?Cecilia De Almeida,?Birgit Edlich,?Rainer Fietkau
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1007/s00066-016-0941-8

Springer

Abstract：Background: Concurrent chemoradiotherapy (CRT) is considered standard for inoperable stage III non-small cell lung cancer (NSCLC). Consolidation chemotherapy (CC) following CRT is intended t

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

15小时前

biofresh

51b35ed48fd511f1856234735aa3bc31.pdf

15小时前

Book学术机器人

2026/8/4 15:03:10 未找到该文献，机器人已退出，请等待人工下载

2026/8/4 15:03:10 Book学术AI机器人收到请求，开始寻找文献

2026/8/4 15:03:10 已向机器人发送请求

15小时前

123 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierA double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03)